You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Single Arm

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)

Recruiting
  • Gastric Cancer Stage IIIB-IIIC
  • Pembrolizumab + SOX
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 7, 2023

Labor, Induced Trial in Gaborone (Foley or balloon catheter)

Completed
  • Labor, Induced
  • Foley or balloon catheter
  • Gaborone, South East, Botswana
    Princess Marina Hospital
May 22, 2023

Neurodegenerative Diseases Trial (SMARTO ONE)

Not yet recruiting
  • Neurodegenerative Diseases
  • SMARTO ONE
  • (no location specified)
Jul 14, 2023

Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Jul 10, 2023

Metastatic Breast Cancer Trial in Birmingham (Capecitabine Pill)

Not yet recruiting
  • Metastatic Breast Cancer
  • Capecitabine Pill
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 23, 2023

MDS Trial (Roxadustat in combination with retinoic acid)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Roxadustat in combination with retinoic acid
  • (no location specified)
Aug 26, 2023

Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Jul 31, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Duvelisib, Chidamide
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Jul 27, 2023

Ovarian Epithelial Carcinoma Trial (SZ011 CAR-NK)

Not yet recruiting
  • Ovarian Epithelial Carcinoma
  • SZ011 CAR-NK
  • (no location specified)
May 3, 2023

Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Jun 26, 2023

Atrial Fibrillation Trial (CLAAS® System)

Not yet recruiting
  • Atrial Fibrillation
  • CLAAS® System
  • (no location specified)
Sep 19, 2023

Advanced Hepatocellular Carcinoma Trial (SZ003 CAR-NK)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • SZ003 CAR-NK
  • (no location specified)
Apr 25, 2023

Sleep, Mood, Caffeine Withdrawal Trial in Santa Monica (Clevr Sleeptime, Clevr Matcha, Clevr Chai)

Active, not recruiting
  • Sleep
  • +4 more
  • Clevr Sleeptime
  • +2 more
  • Santa Monica, California
    Citruslabs
Nov 19, 2023

Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

PTCL Patients Who Achieved Complete Response From Frontline Treatment Trial (Selinexor)

Not yet recruiting
  • PTCL Patients Who Achieved Complete Response From Frontline Treatment
  • (no location specified)
Apr 18, 2023

Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Cholangiocarcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2023

Mycobacterium Avium Complex Pulmonary Disease Trial in Seoul

Not yet recruiting
  • Mycobacterium Avium Complex Pulmonary Disease
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jun 7, 2023

    Phenylketonurias Trial (PKU GOLIKE)

    Not yet recruiting
    • Phenylketonurias
    • PKU GOLIKE
    • (no location specified)
    Apr 12, 2023

    Kaposi Sarcoma, Classic Kaposi Sarcoma, Refractory Kaposi Sarcoma Trial (Pembrolizumab + Lenvatinib)

    Not yet recruiting
    • Kaposi Sarcoma
    • +2 more
    • Pembrolizumab + Lenvatinib
    • (no location specified)
    Apr 27, 2023

    Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)

    Recruiting
    • Colon Cancer
    • Chimeric antigen receptor T cell preparation targeting GCC
    • Qingdao, Shandong, China
      The Affiliated Hospital of Qingdao University
    May 16, 2023

    Cancer Trial in Rochester (SONATA)

    Not yet recruiting
    • Cancer
    • SONATA
    • Rochester, New York
      University of Rochester
    Feb 24, 2023

    Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)

    Not yet recruiting
    • Neuroendocrine Carcinoma
    • Surufatinib and Serplulimab
    • Wuhan, Hubei, China
      Cancer Center, Union Hospital, Tongji Medical College, Huazhong
    Feb 18, 2023

    A Multi-Centre, Single-arm, Observational Study of EVUSHELD in

    Active, not recruiting
    • COVID-19
      • Qionghai, Hainan, China
        (2) Ruijin-Hainan Hospital Shanghai Jiaotong University School o
      Jun 21, 2023

      Lung Cancer, TKI Resistance, EGFR Sensitive Mutation Trial (Anlotinib, Penpulimab)

      Not yet recruiting
      • Lung Cancer
      • +4 more
      • (no location specified)
      Sep 15, 2023